INSIGHT-Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine
* Astra research chief: Successful half dose 'serendipity'* Oxford scientist: Dosing was a deliberate decision* Confusion raises questions on robustness of data - experts* Rare public dissonance between collaborators on a big projectBy Ludwig Burger...
